Jorge Ivan Castillo-Quan, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Longevity | 6 | 2020 | 1050 | 1.210 |
Why?
|
| Lithium | 2 | 2019 | 596 | 0.960 |
Why?
|
| Glycogen Synthase Kinase 3 | 3 | 2019 | 410 | 0.640 |
Why?
|
| Pyrimidinones | 1 | 2019 | 384 | 0.560 |
Why?
|
| NF-E2-Related Factor 2 | 2 | 2017 | 376 | 0.550 |
Why?
|
| Sirolimus | 2 | 2019 | 1547 | 0.490 |
Why?
|
| Aging | 5 | 2020 | 8652 | 0.480 |
Why?
|
| Pyridones | 1 | 2019 | 792 | 0.460 |
Why?
|
| Hydrocortisone | 4 | 2010 | 1803 | 0.420 |
Why?
|
| Drosophila | 2 | 2019 | 1492 | 0.420 |
Why?
|
| Nutrigenomics | 2 | 2009 | 24 | 0.410 |
Why?
|
| Trans-Activators | 2 | 2012 | 2860 | 0.400 |
Why?
|
| Drosophila melanogaster | 4 | 2020 | 1710 | 0.390 |
Why?
|
| Caenorhabditis elegans | 2 | 2017 | 1444 | 0.370 |
Why?
|
| Insulin | 6 | 2017 | 6596 | 0.330 |
Why?
|
| Adipose Tissue, White | 1 | 2012 | 365 | 0.330 |
Why?
|
| Geriatrics | 1 | 2013 | 387 | 0.320 |
Why?
|
| Metformin | 1 | 2016 | 912 | 0.320 |
Why?
|
| Drosophila Proteins | 5 | 2020 | 1699 | 0.320 |
Why?
|
| Fibronectins | 1 | 2012 | 722 | 0.310 |
Why?
|
| Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2009 | 275 | 0.290 |
Why?
|
| Depressive Disorder | 2 | 2010 | 3726 | 0.270 |
Why?
|
| Cushing Syndrome | 1 | 2008 | 241 | 0.270 |
Why?
|
| Adipose Tissue, Brown | 1 | 2012 | 755 | 0.270 |
Why?
|
| Nerve Growth Factors | 1 | 2009 | 562 | 0.260 |
Why?
|
| Thiazolidinediones | 1 | 2009 | 465 | 0.260 |
Why?
|
| Hyperinsulinism | 1 | 2007 | 402 | 0.230 |
Why?
|
| Polycystic Ovary Syndrome | 1 | 2008 | 377 | 0.220 |
Why?
|
| Diabetes Complications | 1 | 2010 | 1341 | 0.220 |
Why?
|
| Diabetes Mellitus | 2 | 2012 | 5890 | 0.210 |
Why?
|
| Neuroprotective Agents | 1 | 2009 | 961 | 0.200 |
Why?
|
| Autophagy | 3 | 2020 | 1337 | 0.200 |
Why?
|
| Repressor Proteins | 1 | 2011 | 2982 | 0.180 |
Why?
|
| Alzheimer Disease | 3 | 2017 | 8561 | 0.180 |
Why?
|
| Polymorphism, Genetic | 1 | 2009 | 4286 | 0.150 |
Why?
|
| Parkinson Disease | 1 | 2011 | 2859 | 0.140 |
Why?
|
| Neuroaxonal Dystrophies | 1 | 2016 | 26 | 0.140 |
Why?
|
| Nervous System Diseases | 1 | 2007 | 1647 | 0.140 |
Why?
|
| Gaucher Disease | 1 | 2016 | 110 | 0.130 |
Why?
|
| Xenobiotics | 1 | 2016 | 70 | 0.130 |
Why?
|
| Glucosylceramidase | 1 | 2016 | 125 | 0.130 |
Why?
|
| Group X Phospholipases A2 | 1 | 2015 | 1 | 0.130 |
Why?
|
| Group VI Phospholipases A2 | 1 | 2015 | 16 | 0.130 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2016 | 435 | 0.120 |
Why?
|
| Mitochondria | 2 | 2020 | 3601 | 0.120 |
Why?
|
| United Nations | 1 | 2015 | 151 | 0.120 |
Why?
|
| Animals | 13 | 2020 | 167960 | 0.120 |
Why?
|
| Lipid Peroxidation | 1 | 2015 | 271 | 0.120 |
Why?
|
| Insulin Resistance | 1 | 2008 | 3959 | 0.110 |
Why?
|
| Caloric Restriction | 1 | 2016 | 295 | 0.110 |
Why?
|
| Drug Combinations | 1 | 2019 | 2025 | 0.110 |
Why?
|
| Lysosomes | 1 | 2016 | 920 | 0.090 |
Why?
|
| Dietary Carbohydrates | 1 | 2016 | 892 | 0.090 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2017 | 866 | 0.090 |
Why?
|
| Biogenic Monoamines | 1 | 2010 | 50 | 0.090 |
Why?
|
| Neuroglia | 1 | 2016 | 944 | 0.090 |
Why?
|
| Models, Biological | 3 | 2017 | 9468 | 0.090 |
Why?
|
| Insulin-Like Growth Factor I | 2 | 2017 | 1928 | 0.090 |
Why?
|
| Obesity | 1 | 2012 | 12919 | 0.080 |
Why?
|
| Dietetics | 1 | 2008 | 34 | 0.080 |
Why?
|
| Models, Animal | 1 | 2015 | 2117 | 0.080 |
Why?
|
| Stress, Physiological | 1 | 2016 | 1398 | 0.080 |
Why?
|
| Physical Conditioning, Animal | 1 | 2012 | 366 | 0.080 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2016 | 2058 | 0.070 |
Why?
|
| Lipid Metabolism | 1 | 2016 | 1902 | 0.070 |
Why?
|
| Signal Transduction | 5 | 2020 | 23374 | 0.070 |
Why?
|
| Depression | 1 | 2007 | 8045 | 0.070 |
Why?
|
| Antioxidants | 1 | 2015 | 1667 | 0.070 |
Why?
|
| Pituitary-Adrenal System | 1 | 2010 | 551 | 0.070 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2010 | 599 | 0.070 |
Why?
|
| Mexico | 1 | 2009 | 760 | 0.070 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2010 | 699 | 0.070 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2007 | 12289 | 0.070 |
Why?
|
| Receptor, Insulin | 2 | 2020 | 836 | 0.060 |
Why?
|
| Oxidative Stress | 1 | 2015 | 3106 | 0.060 |
Why?
|
| Diabetic Neuropathies | 1 | 2007 | 406 | 0.050 |
Why?
|
| Survival Analysis | 1 | 2016 | 10185 | 0.050 |
Why?
|
| Gene Knockout Techniques | 2 | 2016 | 802 | 0.050 |
Why?
|
| Humans | 14 | 2019 | 760613 | 0.050 |
Why?
|
| Transcription, Genetic | 1 | 2016 | 7593 | 0.050 |
Why?
|
| Diabetic Angiopathies | 1 | 2007 | 822 | 0.050 |
Why?
|
| Metabolic Diseases | 1 | 2008 | 685 | 0.050 |
Why?
|
| Animals, Genetically Modified | 2 | 2017 | 1553 | 0.050 |
Why?
|
| Gene Expression Profiling | 1 | 2017 | 9406 | 0.050 |
Why?
|
| Genes, Mitochondrial | 1 | 2020 | 62 | 0.050 |
Why?
|
| Disease Models, Animal | 2 | 2017 | 18137 | 0.050 |
Why?
|
| Diabetic Nephropathies | 1 | 2007 | 988 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2017 | 4571 | 0.040 |
Why?
|
| Insulin Receptor Substrate Proteins | 1 | 2020 | 557 | 0.040 |
Why?
|
| Antidepressive Agents | 1 | 2010 | 2890 | 0.040 |
Why?
|
| Oleanolic Acid | 1 | 2017 | 42 | 0.040 |
Why?
|
| Thiadiazoles | 1 | 2017 | 64 | 0.030 |
Why?
|
| Lithium Chloride | 1 | 2017 | 82 | 0.030 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2015 | 296 | 0.030 |
Why?
|
| Quality of Life | 1 | 2015 | 13308 | 0.030 |
Why?
|
| Female | 4 | 2019 | 391246 | 0.030 |
Why?
|
| Rats | 1 | 2009 | 23709 | 0.030 |
Why?
|
| Transcription Factors | 1 | 2012 | 12102 | 0.030 |
Why?
|
| Triazoles | 1 | 2017 | 904 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2017 | 1972 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2008 | 12914 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2017 | 5039 | 0.020 |
Why?
|
| Mice | 2 | 2017 | 81209 | 0.020 |
Why?
|
| Axons | 1 | 2016 | 1672 | 0.020 |
Why?
|
| Mass Spectrometry | 1 | 2015 | 2192 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2015 | 2651 | 0.020 |
Why?
|
| Gene Expression | 1 | 2020 | 7587 | 0.020 |
Why?
|
| Neoplasms | 1 | 2016 | 22075 | 0.020 |
Why?
|
| Hypertension | 1 | 2007 | 8595 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2008 | 17790 | 0.020 |
Why?
|
| Aged | 1 | 2019 | 169143 | 0.020 |
Why?
|
| Neurodegenerative Diseases | 1 | 2015 | 1084 | 0.020 |
Why?
|
| Middle Aged | 1 | 2019 | 220359 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2015 | 4089 | 0.020 |
Why?
|
| Protein Binding | 1 | 2017 | 9335 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 2017 | 5132 | 0.010 |
Why?
|
| Amyloid beta-Peptides | 1 | 2017 | 3841 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2020 | 11902 | 0.010 |
Why?
|
| Brain | 1 | 2009 | 26951 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2017 | 18955 | 0.010 |
Why?
|
| Cell Line | 1 | 2015 | 15620 | 0.010 |
Why?
|
| Risk Factors | 1 | 2008 | 74333 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2017 | 16932 | 0.010 |
Why?
|
| Male | 1 | 2016 | 359718 | 0.010 |
Why?
|
| Neurons | 1 | 2017 | 9424 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2008 | 9288 | 0.010 |
Why?
|
| Mutation | 1 | 2017 | 29957 | 0.010 |
Why?
|
| Pregnancy | 1 | 2008 | 29746 | 0.000 |
Why?
|